Elicio Therapeutics, Inc. ELTX
1.84
(0.04)
(2.13%)
as of 25 Sep
- Market cap
- $53.4M
- P/E
- 0.0×
Follow ELTX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.16 | 2.29 | 2.07 | 2.55 | |
Current Ratio |
3.29 | 2.38 | 2.24 | 2.77 | |
Net Debt/EBITDA |
1.40 | 1.09 | 0.53 | 1.38 | |
Debt/Assets |
34.37% | 36.37% | 41.76% | 30.43% | |
Debt/Equity |
2.55 | 5.75 | (6.59) | 1.20 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.10 | 0.88 | 0.98 | 0.99 | |
Capex/Depreciation |
0.00 | (0.03) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.66) | (0.44) | (0.64) | (0.42) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.66) | (0.44) | (0.64) | (0.42) | |
Cash per Share |
1.23 | 1.21 | 0.82 | 1.22 | |
Shareholders Equity per Share |
0.23 | 0.11 | (0.08) | 0.41 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.23 | 0.11 | (0.08) | 0.41 | |
Free Cash Flow |
(11.09) | (6.81) | (11.64) | (8.16) | |
Working Capital |
14.95 | 11.20 | 8.97 | 16.28 | |
Capital Expenditures |
— | (0.02) | — | — | |
Net Current Asset Value |
(3.00) | (4.91) | (7.93) | 2.09 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.15 | 0.86 | 2.15 | 2.35 | |
Average Assets |
33.34 | 27.02 | 25.42 | 30.43 | |
Average Common Equity |
(7.58) | (4.84) | 3.73 | 4.89 |
Columns are period end dates